Mexiletine-Induced Esophageal Ulceration: Two Case Reports and a Review of the Literature
Reports · 18.01.2025 · 8 (1) · 9
DOI: 10.3390/reports8010009 ↗Kurz gefasst
Fallbericht in der Zeitschrift Reports, online erschienen am 18.01.2025. Verfasst von Matteo Ghisa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Oncology and Gastroenterology, University of Padua, 35124 Padua, Italy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Clinical Significance: Mexiletine is a class 1B antiarrhythmic drug commonly prescribed for ventricular arrhythmias and neuropathic pain. It works as a blocker of the sodium channel that modulates cardiac conduction and reduces aberrant nerve signaling. While it is generally well tolerated, gastrointestinal side effects, such as nausea, vomiting, and abdominal pain, are relatively common. Esophagitis and esophageal ulcerations have been described as rare side effects; however, they are poorly documented in the literature. Esophageal ulceration induced by oral medications, termed pill esophagitis, occurs due to prolonged contact between the medication and the esophageal mucosa. Factors contributing to this phenomenon include improper administration, such as swallowing without sufficient water, taking medication before lying down, or inherent irritant properties of the drug itself. Mexiletine-induced esophageal ulceration has not been extensively reported, making such cases clinically significant and worth investigating. In particular, the prompt diagnosis of mexiletine-induced esophageal injury is essential for timely treatment initiation or the discontinuation of the drug, preventing complications such as bleeding, strictures, or perforation. Altogether, these actions are important to prevent the onset of potentially serious complications, such as bleeding, strictures, and the perforation of the esophagus. Case Presentation: Two different patients were included in this case report on mexiletine-induced esophageal ulceration: a 78-year-old woman affected by primary dilated cardiomyopathy and atrial fibrillation with high ventricular response and a 19-year-old man affected by dilated cardiomyopathy and systemic sclerosis. Conclusions: This case report underscores the importance of recognizing mexiletine-induced esophageal ulceration, and it advocates for timely diagnosis and management to optimize patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Oncology and Gastroenterology, University of Padua, 35124 Padua, Italy.
- Unit of Gastroenterology, San Bortolo Hospital, Azienda ULSS 8 Berica, 36100 Vicenza, Italy.
- Dipartimento di Medicina, University of Padua, 35124 Padua, Italy.
ORCID-Profile: Matteo Ghisa, Marco Senzolo, Edoardo V Savarino
Zitieren
APA
Ghisa, M., Barbuscio, I., Bonazzi, E., Fassan, M., Barberio, B., Senzolo, M., & Savarino, E. V. (2025). Mexiletine-Induced Esophageal Ulceration: Two Case Reports and a Review of the Literature. Reports, 8(1), 9. https://doi.org/10.3390/reports8010009
Vancouver
Ghisa M, Barbuscio I, Bonazzi E, Fassan M, Barberio B, Senzolo M, et al. Mexiletine-Induced Esophageal Ulceration: Two Case Reports and a Review of the Literature. Reports. 2025;8(1):9. doi:10.3390/reports8010009
BibTeX
@article{Ghisa2025,
author = {Ghisa, Matteo and Barbuscio, Ilenia and Bonazzi, Erica and Fassan, Matteo and Barberio, Brigida and Senzolo, Marco and Savarino, Edoardo V},
title = {Mexiletine-Induced Esophageal Ulceration: Two Case Reports and a Review of the Literature},
journal = {Reports},
year = {2025},
volume = {8},
number = {1},
pages = {9},
doi = {10.3390/reports8010009}
}
EUVIMED